Caption Management, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,101,750
-91.6%
67,800
-90.5%
0.02%
-91.0%
Q1 2024$13,168,578
+1582.3%
712,200
+2748.8%
0.20%
+1718.2%
Q4 2023$782,750
-80.7%
25,000
-87.2%
0.01%
-82.3%
Q3 2023$4,063,800
+208.5%
195,000
+254.5%
0.06%
+158.3%
Q2 2023$1,317,250
-10.8%
55,000
-38.9%
0.02%
+20.0%
Q3 2022$1,476,000
-69.7%
90,000
-74.0%
0.02%
-70.1%
Q2 2022$4,878,000
-37.9%
346,166
+6.8%
0.07%
-28.7%
Q1 2022$7,850,000
+2.0%
324,100
-1.7%
0.09%
+9.3%
Q4 2021$7,697,000
+2056.0%
329,700
+1433.5%
0.09%
+2050.0%
Q3 2021$357,000
-80.6%
21,500
-71.4%
0.00%
-83.3%
Q2 2021$1,836,000
-80.4%
75,300
-79.2%
0.02%
-88.1%
Q1 2021$9,356,000
-0.4%
362,700
+106.3%
0.20%
-6.5%
Q4 2020$9,398,000
+152.6%
175,800
+94.9%
0.22%
+147.1%
Q3 2020$3,721,000
-27.3%
90,200
-14.6%
0.09%
-48.8%
Q2 2020$5,121,000
+8.1%
105,657
-4.6%
0.17%
+6.9%
Q4 2019$4,737,000
+38.7%
110,700
+16.5%
0.16%
-10.7%
Q3 2019$3,416,000
-0.1%
95,000
-25.7%
0.18%
+3.5%
Q2 2019$3,420,000
+81.9%
127,900
+82.7%
0.17%
+65.4%
Q1 2019$1,880,000
+242.4%
70,000
+94.4%
0.10%
+141.9%
Q2 2018$549,00036,0000.04%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 647,833$26,723,00011.32%
GREAT POINT PARTNERS LLC 1,921,563$79,264,0007.13%
Baker Brothers Advisors 41,904,586$1,728,564,0006.91%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 486,000$20,048,0006.47%
Palo Alto Investors LP 1,832,300$75,582,0004.15%
Birchview Capital, LP 204,000$8,416,0002.81%
SECTORAL ASSET MANAGEMENT INC 556,514$22,956,0001.97%
Rock Springs Capital Management LP 1,573,200$64,895,0001.65%
Riggs Asset Managment Co. Inc. 17,470$2,025,0000.85%
PFM Health Sciences, LP 421,087$17,370,0000.80%
View complete list of ACADIA PHARMACEUTICALS INC shareholders